Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Synthetic melanin applied to skin speeds up wound healing.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Melanocytes are important for skin and hair color and protect the skin from UV damage.

EH-MSCs may help treat hair loss by reducing inflammation.

Plant compounds may help manage PCOS, endometriosis, and menstrual issues.

Topical metformin shows promise for treating skin conditions like acne and psoriasis.

Platelet-rich plasma might help with hair growth and skin conditions, but more research is needed to prove its effectiveness and safety.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Adequate testosterone is crucial for men's health and quality of life, but its decline with age needs more research.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Ziziphus jujuba Mills may have health benefits, but more research is needed to confirm its safety and effectiveness.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Asiasari Radix et Rhizoma is safe and has potential for new drug development due to its therapeutic properties.

Sema3A can both slow and speed up wound healing, depending on its form and combination with EGF.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Conditioned media from human amniotic fluid-derived stem cells helps skin heal and protects against aging from sun exposure.

Tretinoin boosts minoxidil's effect on hair loss by increasing enzyme activity.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Researchers found four genes that could help diagnose severe alopecia areata early.